Buserelin

SUPREFACT DEPOT 6,3 mg IMPLANTE EN JERINGA PRECARGADA

6,6 mg implanteSpainSuspendedAuthorised 31 Dec 1995

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Suprefact DepotBrazil · Sanofi-Aventis Farmacêutica LtdaSame brand
Suprefact Depot 2 MonthsCanada · 6.3 MG · Implant · Cheplapharm Arzneimittel GMBHSame brand
Suprefact Depot 3 MonthsCanada · 9.45 MG · Implant · Cheplapharm Arzneimittel GMBHSame brand
Suprefact Intranasal Solution 1MG/MLCanada · 1 MG / ML · Spray · Hoechst Canada INC.Same brand
SuprefactItaly · Impianto · Cheplapharm Arzneimittel GMBHSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Buserelin

SUPREFACT DEPOT 6,3 mg IMPLANTE EN JERINGA PRECARGADA

6,6 mg implanteSpainSuspendedAuthorised 31 Dec 1995

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Suprefact Depot 3 maanden, implantatiestift 9,45 mg

Netherlands · Implantaat · Medcor Pharmaceuticals B.V.

Suprefact Depot 3 maanden, implantatiestift 9,45 mgNetherlands · Implantaat · CHEPLAPHARM Arzneimittel GmbH

AnyNew Zealand · Inj 1 mg per ml, 5.5 ml vial

Packs

Pack	Code	Status
SUPREFACT DEPOT 6,3 mg IMPLANTE EN JERINGA PRECARGADA, 1 jeringa precargada + 2 implantes 3,3 mg	681155

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Buserelin
Strength: 6,6 mg
Dosage form: implante
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Suspended
Status in the register: Suspendido
Authorised: 31 Dec 1995
Registration: 60980
Marketing authorisation holder: Cheplapharm Arzneimittel Gmbh
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

SUPREFACT 100 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASALBuserelin · 1,050 mg · solucion para pulverizacion nasalSpainSuspended